ANN ARBOR STAGE IV GRADE 3 FOLLICULAR LYMPHOMA
Clinical trials for ANN ARBOR STAGE IV GRADE 3 FOLLICULAR LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ANN ARBOR STAGE IV GRADE 3 FOLLICULAR LYMPHOMA trials appear
Sign up with your email to follow new studies for ANN ARBOR STAGE IV GRADE 3 FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
First human test of Triple-Threat cancer drug cocktail
Disease control OngoingThis early-stage study aims to find the safest and most effective doses of two oral drugs, lenalidomide and ibrutinib, when given alongside the standard antibody drug rituximab. It involves 33 adults with previously untreated stage II-IV follicular lymphoma, a type of slow-growin…
Matched conditions: ANN ARBOR STAGE IV GRADE 3 FOLLICULAR LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 04, 2026 02:21 UTC
-
New Three-Drug attack on tough lymphomas
Disease control OngoingThis study is testing a new three-drug combination to control B-cell non-Hodgkin lymphoma. It aims to find the safest dose and see if adding a new immunotherapy drug (ALX148) to two existing drugs (rituximab and lenalidomide) helps patients whose cancer has returned or is newly d…
Matched conditions: ANN ARBOR STAGE IV GRADE 3 FOLLICULAR LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC